Riskpilot← Back to searchSign inGet full accessEngvall Medical AB
ABIn liquidationOrg 5569805921VärnamoHospital activities · NACE 8610Est. 20140 employees
Revenue 2019
SEK 165K
-40% vs 2018
EBITDA margin
76.4%
-40% vs 2018
Equity ratio
96.7%
Financial strength
Net profit 2019
SEK 97K
-20% vs 2018
| Revenue | SEK 165K | -40% |
| EBITDA | SEK 126K | -40% |
| Net profit | SEK 97K | -20% |
| Total assets | SEK 511K | -13% |
| Equity | SEK 494K | +24% |
| Employees | 0 | — |
Legal name
Engvall Medical AB
Org number
5569805921
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
25 augusti 2014
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-08-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Aktiebolaget ska bedriva konsultverksamhet inom hälso- och sjukvård, med i första hand inriktning på ortopedi och radiologi, samt förvalta av företaget ägd egendom
Address
Värnamo
Email
bs@amberadvokater.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenue | 41 | 217 | 582 | 274 | 165 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 46 | 183 | 515 | 209 | 126 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 46 | 183 | 515 | 209 | 126 |
| Net financials | — | — | — | — | — |
| Profit before tax | 46 | 158 | 465 | 157 | 126 |
| Tax | −0 | −35 | −102 | −35 | −29 |
| Net profit | 46 | 123 | 363 | 122 | 97 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Total assets | 99 | 260 | 565 | 588 | 511 |
| Equity | 96 | 219 | 425 | 397 | 494 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 | 16 | 65 | 63 | 111 |
| Total debt | 3 | 16 | 65 | 63 | 111 |
EBITDA margin
76.4%
This company
15.8%
Market median
+384% vs market
20152019
Equity ratio
96.7%
This company
38.2%
Market median
+153% vs market
20152019
Return on equity
19.6%
This company
18.4%
Market median
+7% vs market
20152019
Net profit margin
58.8%
This company
8.1%
Market median
+626% vs market
20152019
Asset turnover
0.32×
This company
1.12×
Market median
-71% vs market
20152019
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20152019
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2014-08-01 – 2015-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BJ Liquidator | Liquidator | 2022 |
| Former (1) | ||
EA Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Engvall Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Andreas Engvall | Chief Executive Officer | 0 companies |
| Bertil Jörgen Stridh | Liquidator | 0 companies |
| Angelica Engvall | Deputy Board Member | 0 companies |